Biospectal's logo

Biospectal Stock and Valuation

Healthcare Devices and Supplies
Year Founded
2017
Headquarters
Lausanne, Switzerland
Employees
17

Biospectal Valuation Estimate

Based on UpMarket valuation model
$8.85 million

Biospectal Valuation as of Last Funding Round

As of 07/21/21, according to PitchBook Data, Inc.
$9.77 million

Want to buy Biospectal stock?

I am an accredited investor and understand that UpMarket has a minimum investment of $50,000.
People like you have invested
over $150 million with UpMarket
Biospectal Trend Score
Cold trend level: Cold
Trending Pre-IPO Companies

Instanda

Blazing trend level: Blazing

Magic Leap

Blazing trend level: Blazing

Rothy's

Blazing trend level: Blazing

Pilot

Hot trend level: Hot

Fairmatic

Warm trend level: Warm
View More

Biospectal Company Overview

Biospectal SA is a digital health company focused on transforming blood pressure monitoring through innovative smartphone-based technologies. Their mission is to make blood pressure monitoring accessible and actionable for the global population. Biospectal's software, developed in collaboration with the Swiss Center for Electronics and Microtechnology, enables optical measurement of blood flow through the skin, which their proprietary algorithm uses to determine blood pressure values. Founded in July 2017 and headquartered in Lausanne, Switzerland, Biospectal has raised $4.3M in seed funding and aims to address hypertension, the world's number one chronic health condition.

Biospectal Valuation History

Biospectal Stock Price

The stock price of Biospectal can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.

For illustrative purposes, however, assuming Biospectal has issued 250 million shares, at the estimated UpMarket valuation of $8.85 million, each share of Biospectal stock would be worth $0.04.

Buy Biospectal Stock

If you would like to buy shares in Biospectal, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”

One of our investor relations team members will contact you to discuss Biospectal stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.

UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Biospectal as well.

Biospectal Management

Name Position
ELIOTT JONES CEO
TIMOTHY CATLIN CTO

Biospectal Investors

MassChallenge

Ascend Elements, Turo, AlphaSense, Beewise, Embr Labs, Kuona, Lyfegen, Starling Medical, TCARE

Labcorp Ventures

Evvy, Aetion

Privilège Ventures

LEVY Health

Biospectal Related Companies

About UpMarket

UpMarket's mission is to unlock the private markets for individual investors.

We provide access to a range of asset classes and investment strategies that span private equity, hedge funds, crypto, real estate, and other alternative assets.

The problem

Historically, accessing private market investments had these challenges:
  • A large barrier to entry due to high investment minimums
  • Time-intensive because sourcing deals is a lot of work even if you’ve got a great network, and
  • Costly because of investment-related diligence costs, paperwork, and legal fees

The solution

UpMarket works to address these barriers for individual investors by:
  • Offering lower investment minimums
  • Sourcing and conducting diligence on opportunities for investors, empowering them to pick and choose from pre-screened opportunities
  • Making the investment process entirely digital, straightforward, and easy to manage from a single portal
Individuals like you have invested over $150 Million with UpMarket.

UpMarket Investment Curation Process

Upmarket curates and conducts diligence on every investment opportunity we offer.

We review every offering’s strategy, risk management, liquidity management, fees and expenses, valuation methodology, tax matters, as well as the fund’s third-party providers including legal counsel, auditor, administrator, and custodian.

We aim to offer our clients investments from disciplined managers that pursue unique strategies across an array of asset classes.

Our goal is to empower you to build a portfolio that best meets your individual Investment objectives.

Unlock the private markets today, with UpMarket.